Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

10%

1 trials in Phase 3/4

Results Transparency

38%

3 of 8 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A

5(62.5%)

Phase 2

2(25.0%)

Phase 3

1(12.5%)

8Total

N/A(5)

Phase 2(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT03326713Not ApplicableCompleted

Genetic Risk Assessment for Cancer Education and Empowerment (GRACE) Project

Role: collaborator

NCT03582137Phase 2Completed

A Study of Tolerability and Efficacy of Cannabidiol on Motor Symptoms in Parkinson's Disease

Role: collaborator

NCT03014271Not ApplicableCompleted

Primary Prevention Youth Suicide Trial in Colorado High Schools Prevention Among Colorado High School Students

Role: collaborator

NCT02523183Unknown

The Use of Medicinal Cannabinoids as Adjunctive Treatment for Medically Refractory Epilepsy

Role: collaborator

NCT02735954Unknown

Colorado Marijuana Users Health Cohort

Role: collaborator

NCT02818777Phase 2Completed

A Study of Tolerability and Efficacy of Cannabidiol on Tremor in Parkinson's Disease

Role: collaborator

NCT00542360Not ApplicableCompleted

Marketing Fall Prevention Classes to Older Adults in Faith-Based Congregations

Role: collaborator

NCT01044927Phase 3Completed

Advanced eHealth for Chronic Obstructive Pulmonary Disease (COPD) in Colorado

Role: collaborator

NCT00829491Not ApplicableCompleted

Denver Health Cardiovascular Disease (CVD) Prevention Program

Role: collaborator

NCT00362791Not ApplicableCompleted

Project RESPECT: The Efficacy of HIV/STD Prevention Counseling

Role: collaborator

All 10 trials loaded